register

News & Trends - Pharmaceuticals

Call for legislated consumer voice in HTA

Health Industry Hub | April 11, 2024 |

Pharma News: The consultation period for the Co-design of an Enhanced Consumer Engagement Process in health technology assessment (HTA) recently concluded, with the Consumer Health Forum (CHF) advocating for a legislative mandate to involve consumers.

CHF has firmly backed the integration of consumer voices across critical touchpoints along the entire health technology pathway. The peak consumer body supports the inclusion of First Nations communities and socially and culturally diverse/underrepresented groups.

“If not legislated as a requirement, the consumer engagement framework risks being implemented ineffectively, possibly jeopardising benefits to both consumer and HTA processes,” CHF said in its submission.

Additionally, consumers should be informed about how their input influences reimbursement decision-making. This allows the HTA process to elevate itself from a “dollars and cents” view of health and provide recommendations that consider broader economic and social impacts. CHF supports the development of a checklist to assist decision-makers in integrating equity considerations.

Pre-listing status reports for new medicines should be published using plain language communications to describe the timeline for negotiations and the reasons for any delay. Establishing a path for consumers to initiate a post-market review about their experiences and usage of health technology is also recommended.

In recognising the interplay between the commercial and clinical aspects within the HTA process, CHF is supporting consumer roles for both clinical and commercial input.

“However, there’s a potential for conflict of interest, whether real or perceived, in this approach,” the organisations said. Thus, the CHF is urging the legislation to actively pursue balance in HTA consumer consultation processes through various means, such as ensuring a quota among selected consumers with no prior involvement in the pharmaceutical and medical fields.

“CHF strongly advocates for a collaborative process by which consumers are nominated, vetted, and trained with oversight from health consumer peak bodies. Such an approach will likely increase trust in the independence of health consumer input into HTA processes,” the organisation stated.

The final recommendations will be submitted in a report to the Federal Minister for Health and Aged Care, Mark Butler MP, by 30 June 2024.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


ESG

Edwards Lifesciences VP challenges us to 'dream bigger' for underserved communities

Edwards Lifesciences VP challenges us to ‘dream bigger’ for underserved communities

Health Industry Hub | November 11, 2024 |

Social Impact: Edwards Lifesciences ANZ held its annual Foundation Grants Day, an event that brought to life the company’s commitment […]

More


News & Trends - MedTech & Diagnostics

Government faces scrutiny for inaction in private hospital sector despite Health Check warnings

Government faces scrutiny for inaction in private hospital sector despite Health Check warnings

Health Industry Hub | November 11, 2024 |

Shadow Health Minister Senator Anne Ruston questioned the Department of Health’s commitment to addressing critical issues in the private hospital […]

More


News & Trends - MedTech & Diagnostics

Australia lags behind in funding pharmacogenomic testing: Pathologists urge action

Australia lags behind in funding pharmacogenomic testing: Pathologists urge action

Health Industry Hub | November 11, 2024 |

Diagnostics & MedTech News: The call for urgent action to improve access to pharmacogenomic testing across Australia comes as demand […]

More


News & Trends - Pharmaceuticals

Australia’s first Cholesterol Awareness Week launched to tackle nation’s 'silent disease'

Australia’s first Cholesterol Awareness Week launched to tackle nation’s ‘silent disease’

Health Industry Hub | November 11, 2024 |

Pharma News: Leading heart charities have come together to launch the nation’s first Cholesterol Awareness Week (11-17 November), aiming to […]

More


This content is copyright protected. Please subscribe to gain access.